Kringle Pharma,Inc.

Corporate Details

ISIN(s):

N/A

LEI:

Country:

Japan

Address:

茨木市彩都あさぎ七丁目７番１５号彩都バイオインキュベータ２０７号

Website:

https://www.kringle-pharma.com/en/

Sector:

Health Care

Industry:

Pharmaceuticals

Description

Kringle Pharma, Inc. is a late clinical-stage biopharmaceutical company dedicated to advancing regenerative medicines through the development of innovative therapies based on recombinant human HGF (Hepatocyte Growth Factor). Focused on treating intractable and rare diseases, Kringle Pharma is conducting clinical trials to harness the protective and regenerative properties of HGF protein. The company's robust manufacturing capabilities ensure the production of high-quality pharmaceutical-grade HGF, positioning it as a leader in the field. By promoting the development of therapeutic agents aimed at addressing unmet medical needs, Kringle Pharma aims to transform the lives of patients globally, offering hope where few treatment options exist.